Acrisorcin - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for acrisorcin and what is the scope of patent protection?
Acrisorcin
is the generic ingredient in one branded drug marketed by Schering and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for acrisorcin
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 17 |
Patent Applications: | 1,370 |
DailyMed Link: | acrisorcin at DailyMed |
US Patents and Regulatory Information for acrisorcin
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Schering | AKRINOL | acrisorcin | CREAM;TOPICAL | 012470-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |